Disc Medicine (IRON) Competitors $62.50 -1.62 (-2.53%) (As of 11:06 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IRON vs. RVMD, LNTH, LEGN, NUVL, ELAN, CYTK, BPMC, BBIO, TGTX, and CRNXShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Revolution Medicines (RVMD), Lantheus (LNTH), Legend Biotech (LEGN), Nuvalent (NUVL), Elanco Animal Health (ELAN), Cytokinetics (CYTK), Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), and Crinetics Pharmaceuticals (CRNX). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Revolution Medicines Lantheus Legend Biotech Nuvalent Elanco Animal Health Cytokinetics Blueprint Medicines BridgeBio Pharma TG Therapeutics Crinetics Pharmaceuticals Disc Medicine (NASDAQ:IRON) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Is IRON or RVMD more profitable? Disc Medicine's return on equity of -25.24% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -25.24% -23.96% Revolution Medicines N/A -33.67%-30.08% Do analysts rate IRON or RVMD? Disc Medicine presently has a consensus price target of $87.50, suggesting a potential upside of 36.46%. Revolution Medicines has a consensus price target of $65.82, suggesting a potential upside of 48.88%. Given Revolution Medicines' higher probable upside, analysts plainly believe Revolution Medicines is more favorable than Disc Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Does the media prefer IRON or RVMD? In the previous week, Disc Medicine had 4 more articles in the media than Revolution Medicines. MarketBeat recorded 4 mentions for Disc Medicine and 0 mentions for Revolution Medicines. Disc Medicine's average media sentiment score of 0.82 beat Revolution Medicines' score of 0.00 indicating that Disc Medicine is being referred to more favorably in the media. Company Overall Sentiment Disc Medicine Positive Revolution Medicines Neutral Which has more volatility and risk, IRON or RVMD? Disc Medicine has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Does the MarketBeat Community prefer IRON or RVMD? Revolution Medicines received 41 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 84.48% of users gave Disc Medicine an outperform vote while only 75.63% of users gave Revolution Medicines an outperform vote. CompanyUnderperformOutperformDisc MedicineOutperform Votes4984.48% Underperform Votes915.52%Revolution MedicinesOutperform Votes9075.63% Underperform Votes2924.37% Do institutionals and insiders hold more shares of IRON or RVMD? 83.7% of Disc Medicine shares are owned by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are owned by institutional investors. 4.2% of Disc Medicine shares are owned by insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, IRON or RVMD? Disc Medicine has higher earnings, but lower revenue than Revolution Medicines. Disc Medicine is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$76.43M-$3.98-16.11Revolution Medicines$742K10,022.86-$436.37M-$3.59-12.31 SummaryRevolution Medicines beats Disc Medicine on 9 of the 16 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.>> Register for the Workshop Now Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.91B$6.66B$5.21B$9.13BDividend YieldN/A2.96%4.96%4.20%P/E Ratio-16.1110.6087.1517.20Price / SalesN/A200.651,126.34123.94Price / CashN/A57.1543.2737.85Price / Book4.535.184.875.00Net Income-$76.43M$150.98M$120.16M$225.21M7 Day Performance0.49%2.38%2.07%3.81%1 Month Performance1.06%-5.18%17.10%2.69%1 Year Performance11.01%7.67%29.41%18.12% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine3.0562 of 5 stars$62.50-2.5%$87.50+40.0%+11.0%$1.86BN/A-15.7078RVMDRevolution Medicines4.1274 of 5 stars$43.80-0.6%$65.82+50.3%+54.1%$7.37B$742,000.00-12.20443Gap DownLNTHLantheus4.3091 of 5 stars$90.76+1.6%$131.86+45.3%+48.5%$6.31B$1.50B15.10834Positive NewsLEGNLegend Biotech1.7995 of 5 stars$33.53-1.6%$81.54+143.2%-46.0%$6.12B$520.18M-35.291,800NUVLNuvalent3.0068 of 5 stars$83.80-0.5%$112.60+34.4%+9.1%$5.95BN/A-24.1540Analyst ForecastELANElanco Animal Health3.7458 of 5 stars$11.74+0.9%$16.71+42.4%-19.1%$5.80B$4.45B29.359,300CYTKCytokinetics4.0899 of 5 stars$49.09+0.5%$84.07+71.3%-43.3%$5.79B$3.22M-9.12250BPMCBlueprint Medicines2.8524 of 5 stars$89.37-0.9%$123.33+38.0%-3.1%$5.68B$434.42M-42.36640Positive NewsBBIOBridgeBio Pharma4.5435 of 5 stars$27.53+3.9%$48.08+74.6%-30.7%$5.20B$217.77M-11.42400TGTXTG Therapeutics4.5173 of 5 stars$32.47+0.8%$40.67+25.2%+90.5%$5.05B$264.79M-324.67290CRNXCrinetics Pharmaceuticals3.8319 of 5 stars$53.98+0.7%$74.40+37.8%+45.7%$5.01B$1.04M-14.47210Positive News Related Companies and Tools Related Companies Revolution Medicines Alternatives Lantheus Alternatives Legend Biotech Alternatives Nuvalent Alternatives Elanco Animal Health Alternatives Cytokinetics Alternatives Blueprint Medicines Alternatives BridgeBio Pharma Alternatives TG Therapeutics Alternatives Crinetics Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRON) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
